• Join
  • Login
  • Contact

FIP Library

FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.

Biowaiver monographs are literature reviews, in which publicly available data are gathered and organised to address the question of whether a biowaiver can be recommended for a new formulation of an active pharmaceutical ingredient (API). Parameters and points discussed are: solubility and permeability, dissolution of dosage forms, pharmacokinetics, the therapeutic use and therapeutic window of the API, data on excipient interactions and problems with bioavailability and/or bioequivalence.

1. Acetaminophen = Paracetamol  2. Acetazolamide  3. Acetylsalicylic acid  4. Aciclovir  5. Amitriptyline Hydrochloride  6. Amodiaquine Hydrochloride  

7. Amoxicillin trihydrate  8. Atenolol  9. Bisoprolol fumarate  10. Chloroquine Phosphate  11. Chloroquine Sulfate  12. Chloroquine Hydrochloride

13. Cimetidine  14. Ciprofloxacin Hydrochloride  15. Codeine phosphate  16. Diclofenac Potassium  17. Diclofenac Sodium  18. Doxycycline Hyclate

19. Efavirenz  20. Enalapril Maleate  21. Ethambutol Dihydrochloride  22. Fluconazole  23. Folic acid  24. Furosemide  25. Ibuprofen  26. Isoniazid

27. Ketoprofen  28. Lamivudine  29. Levetiracetam  30. Levofloxacin  31. Mefloquine Hydrochloride  32. Metoclopramide Hydrochloride

33. Metronidazole; and its erratum  34. Nifedipine  35. Piroxicam  36. Prednisolone  37. Prednisone  38. Primaquine Diphosphate

39. Proguanil Hydrochloride (accepted for publication)  40. Propranolol Hydrochloride  41. Pyrazinamide  42. Quinidine Sulfate

43. Quinine Sulfate  44. Ranitidine Hydrochloride 45. Ribavirin  46. Rifampicin  47. Stavudine  48. Verapamil Hydrochloride

49. Zidovudine (Azidothymidine)

The FIP Global Pharmaceutical Observatory (GPO) is a worldwide data hub to inform the advocacy work of our members and partners.  

The FIP Atlas is a platform being developed to showcase our members’ needs and priorities (supported by the data from the GPO), allowing us to identify opportunities for developing pharmacy with, for and through our member organisations.  

Latest intelligence and data on the state of pharmacy and pharmaceutical science around the world.  


Last update 28 March 2022

FIP Congresses